| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.41▲ | 1.39▲ | 1.40▲ | 1.48▼ | 1.38▲ |
| MA10 | 1.39▲ | 1.39▲ | 1.40▲ | 1.40▲ | 1.29▲ |
| MA20 | 1.40▲ | 1.41▼ | 1.48▼ | 1.35▲ | 1.52▼ |
| MA50 | 1.39▲ | 1.49▼ | 1.42▼ | 1.28▲ | 1.90▼ |
| MA100 | 1.44▼ | 1.40▲ | 1.34▲ | 1.54▼ | 5.25▼ |
| MA200 | 1.49▼ | 1.34▲ | 1.32▲ | 1.70▼ | 9.77▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.002▲ | -0.014▼ | 0.015▲ | 0.064▲ |
| RSI | 56.130▲ | 44.993▼ | 44.913▼ | 53.016▲ | 42.852▼ |
| STOCH | 85.556▲ | 52.315 | 40.054 | 71.917 | 69.258 |
| WILL %R | -22.222▲ | -22.222▲ | -72.000 | -53.763 | -36.123 |
| CCI | 114.899▲ | 140.741▲ | -27.086 | 19.017 | 85.545 |
|
Monday, January 19, 2026 05:01 AM
Biomea Fusion Inc. (NASDAQ:BMEA) is one of the overlooked growth stocks to buy. On January 14, Rodman & Renshaw initiated coverage of Biomea Fusion with a Buy rating and $8 price target. In Q3 2025, ...
|
|
Monday, January 12, 2026 06:19 AM
Advancing icovamenib toward late-stage clinical development in two Phase II clinical trials in patients with insulin-deficient type 2 diabetes (“T2D”) and in T2D patients currently failing ...
|
|
Friday, December 05, 2025 07:00 AM
(RTTNews) - Biomea Fusion Inc. (BMEA) announced that it has presented new data from its COVALENT-111 study evaluating Icovamenib for type-2 diabetes at the 23rd World Congress on Insulin Resistance, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/01/26 | 1.41 | 1.4402 | 1.31 | 1.41 | 1,588,621 |
| 15/01/26 | 1.66 | 1.66 | 1.38 | 1.395 | 2,494,574 |
| 14/01/26 | 1.52 | 1.655 | 1.501 | 1.62 | 2,380,464 |
| 13/01/26 | 1.52 | 1.53 | 1.43 | 1.52 | 1,953,680 |
| 12/01/26 | 1.46 | 1.55 | 1.43 | 1.46 | 2,832,242 |
| 09/01/26 | 1.36 | 1.44 | 1.335 | 1.42 | 1,475,120 |
| 08/01/26 | 1.34 | 1.36 | 1.27 | 1.34 | 789,029 |
| 07/01/26 | 1.24 | 1.365 | 1.24 | 1.33 | 900,926 |
| 06/01/26 | 1.28 | 1.28 | 1.225 | 1.26 | 599,157 |
| 05/01/26 | 1.35 | 1.36 | 1.27 | 1.28 | 883,689 |
|
|
||||
|
|
||||
|
|